Brodalumab: Seven-Year US Pharmacovigilance Report

By afschroeder • July 30, 2025

Lebwohl MG, Koo JY, Armstrong AW, Strober BE, Yoon SH, Rawnsley NN, Goehring EL Jr, Jacobson AA. Brodalumab: Seven-Year US Pharmacovigilance Report. Dermatol Ther (Heidelb). 2025 Jul 29. doi: 10.1007/s13555-025-01497-w. Epub ahead of print. PMID: 40730908.

Tags: Adverse events, Dermatology, Drug reaction, psoriasis, Publications, real-world, safety

Squamous Eccrine Ductal Carcinoma: A Comprehensive Review of the Clinicopathologic Features and Management in 27 Cases

Gudino-Rosales S, Lilley CM, Gates G, Kneiber D. Squamous Eccrine Ductal Carcinoma: A Comprehensive Review of the Clinicopathologic Features and Management in 27 Cases. Cureus.[...]

Eczematous Neurodermatitis Following Total Knee Arthroplasty: Expanding Awareness of a Rare and Underdiagnosed Postoperative Dermatologic Complication

Jolkovsky E, Zeegen E, Ahronowitz I. Eczematous Neurodermatitis Following Total Knee Arthroplasty: Expanding Awareness of a Rare and Underdiagnosed Postoperative Dermatologic Complication. Cureus. 2025 Jun[...]

Bidirectional risk relationship between autoimmune blistering diseases and monoclonal gammopathies: A large-scale matched cohort study

Curman P, Ngo BT, Ludwig RJ, Kasperkiewicz M. Bidirectional risk relationship between autoimmune blistering diseases and monoclonal gammopathies: A large-scale matched cohort study. JAAD Int.[...]